[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

North America Market Research Reports & Industry Analysis

Publications found: 97,050
Sort by:

IVERIC bio, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

IVERIC bio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pieris Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Pieris Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ultragenyx Pharmaceutical Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Ultragenyx Pharmaceutical Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

DarioHealth Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

DarioHealth Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Flex Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Flex Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Fortress Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Fortress Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NantKwest Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

NantKwest Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caredx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Caredx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Crispr Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Crispr Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Foamix Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Foamix Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Intercept Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Intercept Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Recro Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Recro Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aptevo Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Aptevo Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sesen Bio, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Sesen Bio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NanoString Technologies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

NanoString Technologies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

SCYNEXIS, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

SCYNEXIS, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

vTv Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

vTv Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Argos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Argos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

INC Research Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

INC Research Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Proteostasis Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Proteostasis Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TRACON Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

TRACON Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Corbus Pharmaceuticals Holding Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Corbus Pharmaceuticals Holding Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Enanta Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Enanta Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Epizyme Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Epizyme Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AC Immune Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

AC Immune Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Veracyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Veracyte Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Horizon Pharma PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Horizon Pharma PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Retrophin Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Retrophin Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Supernus Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Supernus Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Adaptimmune Therapeutics Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Adaptimmune Therapeutics Plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Clearside Biomedical Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Clearside Biomedical Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Organovo Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Organovo Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CytomX Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

CytomX Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Insys Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Insys Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Miragen Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Miragen Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Onconova Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Onconova Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AcelRx Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

AcelRx Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alder BioPharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Alder BioPharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ChemoCentryx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

ChemoCentryx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Fate Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Fate Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nabriva Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Nabriva Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Neos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OncoMed Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

OncoMed Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TG Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

TG Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ADMA Biologics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

ADMA Biologics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Altimmune Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Altimmune Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Chimerix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Chimerix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

EyeGate Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

EyeGate Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tocagen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Tocagen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Dermira, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

 US$ 499.00

Dermira, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Clear all

Search

Categories

4,016
3,705
2,886
2,530
2,008
1,590
1,200
1,066
1,056
1,005
871
857
778
738
603
553
550
489
473
437
416
372
348
341
306
275
270
270
264
258
256
200
186
184
173
142
114
105
103
91
87
80
79
74
73
62
60
59
57
52
52
49
47
46
44
41
40
36
35
35
33
31
31
29
28
26
25
25
24
22
22
21
20
20
19
17
16
15
15
14
12
12
11
11
11
11
10
10
10
10
9
9
9
9
9
8
8
8
8
8
7
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
7
6
5
1
8
2
2
1
1
5
4
2
12
2
16
1
1
8
1
1
74
32
2
2
24
3
36
39
3
1
5
11
7
6
6
6
6
5
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
434
6
24
2
27
7
3
8
2
1
8
1
8
74
16
24
3
1
8
7
1
2,760
2
1
8
5
19
14
12
11
11
10
9
9
8
8
7
6
6
5
4
4
4
4
4
4
3
3
2
2
2
2
1
1
1
4
3
2
4
7
5
4
3
2
2
2
2
2
1
8
1
1
15
3
9
1
5
6
4
3
1
7
3
2
1
1
3
5
3
1
1
15
5
8
103
5
7
2
2
1
1
3
3
1
5
3
2
3,972
513
481
405
331
269
206
196
187
117
110
80
79
64
61
55
52
51
50
46
45
44
42
39
39
33
29
27
27
24
21
16
16
12
12
12
11
11
10
10
10
9
9
9
9
9
9
8
8
8
8
8
8
8
7
7
7
7
7
7
6
6
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
1
7
10
4
3
3
3
2
2
1
1
2
107
9
2
5
13
4
12
3
120
5
4
9
7
5
4
3
3
179
86
10
3
4
3
3
2
1
2
4
1
11
4
1
14
10
8
6
3
2
1
1
1
58
13
671
144
140
78
73
65
61
42
38
37
36
35
34
27
24
23
17
16
16
15
14
12
11
10
10
7
7
5
5
4
4
4
3
3
1
1
10
8
2
70
1
1
9
6
2
2
6
17
1
1
2
108
3
2
8
6
5
4
4
1
4
24
1
8
6
1
1
3
2
1
2
7
2
4
6
4
1
1
8
3
2
1
2
2
9
63
258
4
1
3
1
5
1
14
40
8
55
2
2
3
3
7
3
114
29
5
2
9,026
15
3
48
245
83
2
101
1
4
22
39
446
16
24
655
26
145
171
29
80
4
4
44
26
209
4
50
46
28
17
7
1
19
7
1
1
1
16
72
4
5
2
98
12

Publishers

15,092
13,573
7,070
881
236
126
120
106
19
14
6,959
1,146
1,034
4
234
117
160
3
12
32
2
646
7,395
93
1
4,194
391
5,213
1
11
1
10,002
53
2
1
2
2
6
10
8
618
2
3
5
18
57
4,997
1
9
1,519
2
175
2
7
5
96
417
2
224
2
180
51
196
13
5,936
422
1,029
2
2
15
4
19
6
49
741
27
4
11
125
17
158
3,899
2
217
8
53
13
161
158
2
17
17
27
27
80
49
154
6
3

Regions

11,703
4,264
1,040
887
858
830
822
822
787
465
412
358
348
311
211
80
44
43
43
15
13
6
3
1
1
1
1
751
20,260
301
351
2
1
51,015

Price

—

Date

—

Pages

—

Offers

417
1